Clinical Trials Directory

Trials / Sponsors / Grupo Español Multidisciplinar de Melanoma

Grupo Español Multidisciplinar de Melanoma

Academic / Other · 12 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingNeoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
Mestastatic Uveal Melanoma
Phase 22025-07-18
RecruitingPLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
Melanoma
Phase 22025-06-10
RecruitingEncorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Sym
Melanoma BRAF V600E/K Mutated, Melanoma and Brain Metastases
Phase 22025-05-29
CompletedSitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.
Uveal Melanoma
Phase 22022-09-23
WithdrawnDurvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Uveal Melanoma, Metastatic Cancer
Phase 22020-05-01
CompletedEncorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Bra
Metastatic Melanoma, Brain Metastases
Phase 22019-07-18
RecruitingDescriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Melanoma Stage Iv, Melanoma Stage Iii, Advanced Cancer
—2018-08-07
CompletedTrial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melan
Uveal Melanoma
Phase 22016-04-01
CompletedClinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermi
Melanoma
Phase 22015-06-30
CompletedRetrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain
Malignant Melanoma Stage IV, Malignant Melanoma Stage IIIc
—2015-03-03
CompletedGEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases
Melanoma, Brain Metastases
Phase 22014-04-04
CompletedTranslational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Stage IV Skin Melanoma
—2013-04-01